Endless schreef op 25 mei 2023 12:25:
Orphan Tag Granted to Opdivo, Leniolisib, and 6 More APIs
May 24, 2023
Japan’s health ministry on May 23 granted orphan drug designation for eight APIs including Ono Pharmaceutical’s cancer drug Opdivo (nivolumab) for a new indication and Pharming Technologies’ PI3Kd inhibitor leniolisib. Opdivo was designated for the proposed indication of unresectable, advanced/relapsed…
Goedkeuring dus in Japan